Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

Fig. 6

Growth response curves of ovarian cancer cell line pairs treated with glycolysis inhibitors. IOM-1190 was used at concentrations between 0.2-100μΜ, STF31 and 3PO at concentrations between 0.06-30μΜ and oxamic acid at concentrations between 0.4-100mΜ for a 4-day period. Cell viability was determined by an SRB assay. Mean results of 6 replicates are reported and error bars represent standard deviations. Values are shown as a percentage of control. A constant 1% DMSO concentration was used across the whole curve for IOM-1190 and a respective constant 0.3% DMSO concentration for STF31 and 3PO. IC50 concentrations are listed in Table 1

Back to article page